Related Experiment Video

Updated: Oct 25, 2025

Evaluation of Keratinocyte Proliferation on Two- and Three-dimensional Type I Collagen Substrates
08:19

Evaluation of Keratinocyte Proliferation on Two- and Three-dimensional Type I Collagen Substrates

Published on: April 22, 2019

7.2K

Beta2-adrenergic receptor agonist inhibits keratinocyte proliferation by mechanisms involving nitric oxide

Chieh-Shan Wu1, Der-An Tsao2, Huoy-Rou Chang3

  • 1Department of Dermatology, Kaohsiung Veterans General Hospital, Kaohsiung city, Taiwan.

Postepy Dermatologii I Alergologii
|August 11, 2021
PubMed
Abstract

Insights

Beta2-adrenergic receptor agonists stimulate nitric oxide production in skin cells, influencing keratinocyte proliferation. This interaction highlights a potential therapeutic target for skin conditions related to nitric oxide signaling.

Area of Science:

  • Dermatology
  • Molecular Biology
  • Pharmacology

Background:

  • Beta2-adrenoceptors (β2-ARs) play a role in regulating keratinocyte proliferation.
  • Nitric oxide (NO), produced by keratinocytes via nitric oxide synthase (NOS), mediates this proliferation.

Purpose of the Study:

  • To investigate the interaction mechanism between β2-adrenergic receptors and NO production in keratinocytes.
  • To elucidate the role of this interaction in keratinocyte proliferation.

Main Methods:

  • Keratinocytes were treated with varying concentrations of isoproterenol (a β2-AR agonist) and L-NMMA (a NOS inhibitor).
  • Assays included examination of NOS expression, NO production, cyclic AMP (c-AMP) levels, and keratinocyte proliferation.

Main Results:

  • Isoproterenol increased inducible NOS (iNOS) and neuronal NOS (ncNOS) protein levels and elevated nitric oxide production.
  • L-NMMA inhibited the isoproterenol-induced increase in iNOS and ncNOS expression and proliferation.

Conclusions:

  • Beta2-adrenergic receptor agonists influence keratinocyte proliferation by mediating nitric oxide synthase.
  • These findings offer potential therapeutic avenues for skin diseases involving dysregulated β-AR-mediated NO production.
Keywords:
keratinocytenitric oxide (NO)nitric oxide synthase (NOS)proliferationβ2-adrenoceptors

More Related Videos

Y-27632 Enriches the Yield of Human Melanocytes from Adult Skin Tissues08:06

Y-27632 Enriches the Yield of Human Melanocytes from Adult Skin Tissues

Published on: July 8, 2020

5.7K
A Simplified and Efficient Method to Isolate Primary Human Keratinocytes from Adult Skin Tissue06:17

A Simplified and Efficient Method to Isolate Primary Human Keratinocytes from Adult Skin Tissue

Published on: August 25, 2018

10.4K

Related Concept Videos

Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
5.4K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.1K
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
6.2K
Antihypertensive Drugs: Vasodilators01:23

Antihypertensive Drugs: Vasodilators

Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
1.6K
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
10.1K
Feedback Inhibition00:46

Feedback Inhibition

Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
55.8K